EDUCATIONal ARTICLE ON Diabetes & Weight Loss With ANTIOBESITY MEDICATIONS (GLP-1) Mounjaro Malaysia

Cliniccleo®

Mounjaro Malaysia – Availability, Benefits & How It Works

Mounjaro Malaysia or Tirzepatide is a breakthrough injectable medication approved for Type 2 diabetes and also effective for weight loss. It works by mimicking gut hormones to control blood sugar and support appetite regulation. Contact us to learn how Tirzepatide can help manage diabetes and aid in sustainable weight reduction.

Understanding Mounjaro (Tirzepatide) and how it assist weight loss In Malaysia

It’s important to understand what Tirzepatide or Mounjaro is and to take it as directed. Make sure you read our treatment summary.

What is Tirzepatide ?

Tirzepatide, is a groundbreaking treatment now available in Malaysia. It is the first dual-action GIP and GLP-1 receptor agonist, designed to support people living with type 2 diabetes and those seeking medically-assisted weight loss.

Tirzepatide works by stimulating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism enhances the body’s insulin production while simultaneously reducing the liver’s sugar output, resulting in better blood sugar control.

Additionally, Tizepatide slows down how food is digested, helping you feel fuller for longer. This appetite suppression can lead to reduced calorie intake and supports effective weight loss—making Tirzepatide in Malaysia a popular option for those seeking sustainable weight management solutions.

How do you take Tirzepatide ?

Tirzepatide, now available in Malaysia, is a revolutionary treatment designed for managing type 2 diabetes and supporting medical weight loss. It is the first dual-action GIP and GLP-1 receptor agonist, targeting two key hormone pathways that regulate blood sugar and appetite.

Tirzepatide works by activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual effect increases the body’s insulin production and decreases the amount of sugar produced by the liver, helping to lower blood sugar levels effectively.

In addition, Tirzepatide slows down digestion, helping you feel fuller for longer. This leads to reduced calorie intake and supports healthy weight loss, making Tirzepatide in Malaysia a promising option for individuals aiming to improve metabolic health.

How effective is Tirzepatide ?

Tirzepatide is taken via a simple, once-weekly injection using the KwikPen. The injection is administered under the skin (subcutaneously)—typically in the stomach, thigh, or upper arm—on the same day each week.

To ensure comfort and effectiveness, it’s important to rotate your injection site weekly. Even if injecting in the same general area, choose a slightly different spot each time.

If you’re planning to start Tirzepatide in Malaysia, consult with a licensed healthcare provider for personalized instructions and support.

Result of Mounjaro (Tirzapatide)

GLP-1 and GIP receptor agonists have demonstrated significant health benefits in clinical studies, showing remarkable potential in managing blood sugar levels, weight, and metabolic health:

Blood sugar control: Clinical studies have shown that Tirzepatide can lower HbA1c levels by up to 2.07%, a substantial improvement in long-term blood glucose control for patients with type 2 diabetes. This positions Tirzepatide in Malaysia as a highly effective treatment option for those seeking better glycemic management.
Weight management: Research demonstrates that Tirzepatide supports sustained weight loss, with some patients achieving up to 20.9% reduction in total body weight. This makes it a valuable medical tool for individuals in Malaysia looking to manage obesity or excess weight.
Metabolic health: Tirzepatide has also shown positive effects on cardiovascular and metabolic markers, including improved blood pressure, lower cholesterol levels, and enhanced energy balance, contributing to better overall metabolic health.

Tirzepatide is not a weight loss drug

Although many patients experience significant weight loss, Tirzepatide or Mounjaro is not officially classified as a weight loss medication. Its primary indication is for the treatment of type 2 diabetes. However, weight loss has been observed as a beneficial side effect in clinical studies. In addition to weight loss, some patients aim for facial contouring. Explore 6 ways to achieving a slimmer face as part of your transformation.

In clinical trials, adults using Tirzepatide (with or without other diabetes medications) experienced an average weight reduction ranging from 12 lbs (on 5 mg) to 25 lbs (on 15 mg).

If you’re exploring Tirzepatide or Mounjaro in Malaysia for its potential weight-related benefits, consult a healthcare provider to see if it’s appropriate for your individual health needs. Learn more about our Aesthetic Clinic & Skin Clinic in Malaysia to discover treatments that complement your diabetes and weight management journey.

Select Safety Information
Do not use Tirzepatide or Mounjaro if you or any of your family have ever had a type of thyroid cancer called MTC or if you have an endocrine system condition called MEN 2, or if you have had a serious allergic reaction to tirzepatide or any of the ingredients.

Who is Mounjaro (Tirzepatide) Indicated for in Malaysia?

Tirzepatide for weight loss is suitable for individuals who are medically classed as overweight or obese and have a BMI in the range of 27-30 upwards (additional eligibility criteria applies). It’s not intended as a quick fix, but is designed to improve overall health and reduce the health-related risks associated with being overweight or obese.

During the consultation stage we’ll ask you for more specific information to ensure Tirzepatide is the right option for you.

Weight loss calculator

Select your current weight:

144 kgs

Weight you could lose: 29 kgs

*This calculator is only an example for illustrative purposes and the results are not guaranteed. Every weight loss experience is unique. This example is based on research showing weight loss of up to 20% over a 72-week period with Tirzepatide.

What to expect in your Mounjaro (Tirzepatide) journey In Malaysia

Studies have shown combining weight loss medications with diet and exercise can have a greater reduction in bodyweight, when monitored over the same time period.

Kickstart your journey

It can take up to 8 weeks to start feeling the effects of your medication, but it will start working in your body after the first injection.

Positive changes

As your dosage increases you should see changes in your weight and your lifestyle.

Sustained weight loss

This is a period where you’ll see sustained weight loss and be in a consistent weight management rhythm.

Once-weekly Tirzepatide Or Mounjaro has multiple dose options

Tirzepatide or Mounjaro in Malaysia, comes in multiple dosage strengths to suit individual treatment needs.

For patients prescribed Tirzepatide (Mounjaro), treatment typically begins with 2.5 mg once weekly. After the first 4 weeks, the dose is usually increased to 5 mg weekly, depending on your response and your doctor’s guidance.

Tirzepatide is designed for once-weekly use. Always follow your doctor’s instructions and consult a licensed medical provider in Malaysia if you have any questions about your Tirzepatide prescription or dosage plan.

What happens next?

During your check-up, let your doctor know how you’re responding to the 2.5 mg and 5 mg doses of Tirzepatide. After reaching 5 mg, you may remain on that dose for longer than 4 weeks. In Malaysia, your doctor will work with you to decide if a higher dose of Tirzepatide is needed.

Your doctor may recommend increasing your Tirzepatide dose based on your progress. After 5 mg, your dose may be raised to 7.5 mg, 10 mg, 12.5 mg, or 15 mg. Each dose level is typically maintained for at least 4 weeks.

Mounjaro Malaysia: Availability, Indications, and Approval Status

Mounjaro (Tirzepatide) is now officially available in Malaysia as of August 30, 2025, following approval by the National Pharmaceutical Regulatory Agency (NPRA). This prescription-only medication is indicated primarily for the management of type 2 diabetes, and may also support medically-supervised weight loss in eligible patients.

Patients interested in Mounjaro in Malaysia must undergo a comprehensive medical consultation to determine whether Tirzepatide is appropriate for their condition, especially considering potential contraindications and health risks. For those seeking Mounjaro for blood sugar control or weight management, speak to your doctor or a certified clinic in Malaysia to begin the evaluation process.

Possible side effects

Talk to your doctor if you have any side effect that bothers you or does not go away.

Everyone can have a different experience, but here are the most common side effects experienced by patients taking Tirzepatide:

Nausea
Diarrhea
Decreased appetite
Vomiting
Constipation
Indigestion
Stomach Pain

In clinical studies, gastrointestinal (GI) side effects such as nausea, vomiting, and diarrhea were commonly reported, particularly during the dose escalation phase of Tirzepatide treatment.

Select Safety Information

Dehydration leading to kidney problems. Nausea, vomiting, and diarrhea can lead to fluid loss (dehydration), which may result in kidney issues. It’s important to stay well-hydrated while taking Tirzepatide to reduce the risk of complications.
Severe stomach problems. Some individuals have reported severe stomach issues while using Tirzepatide. If you experience persistent or intense stomach pain, contact your healthcare provider immediately, as this may indicate a more serious condition.

If you experience nausea, talk to your doctor. In the meantime, some people find the following tips may help:

Eat smaller meals–try splitting your 3 daily meals into 4 or more smaller ones

Stop eating when you feel full

Avoid fat or fatty foods

Try eating foods like toast, crackers, or rice

How to inject tirzapatide

Choose your injection site. Your health care provider can help you choose the injection site that is best for you. You or another person can inject the medicine in your stomach, thighs, or the back of your upper arms. Another person should give you the injection in the back of your upper arm.

Pull off the base cap.

Place the base flat on your skin, then unlock.

Press and hold the button for up to 10 seconds. Listen for the first click. It means the injection has started. The second click means that the injection is complete.

Trusted by hundreds of satisfied clients 5⭐️ reviews on google

MEET OUR DOCTOR

Dr. Raimie Bin Rahmad

Aesthetic Physician

Doctor of Medicine (M.D.) – MMA
Professional Diploma in Aesthetic Medicine
LCP Accredited by MOH
Founder & Medical Director of Cléo Clinic

Dr. Tan Choy Ling

Aesthetic Physician

Doctor of Medicine (M.D.) – MMA
Postgraduate Diploma in Dermatology in Clinical Practice – University of South Wales, UK
Professional Diploma in Aesthetic Medicine – AAA
LCP Accredited by MOH
Co- Founder of Cléo Clinic

Dr. Seok Wye Kitt

Aesthetic Physician

M.D.(RSMU)
Postgraduate Medical Aesthetic Certification (MAC)
Medical Aesthetic International Certification (MAIC)
Clinical Director of Cléo Clinic
LCP Accredited by MOH

Dr. Amy Lau

Aesthetic Physician

M.D.(UKM)
Postgraduate Medical Aesthetic Certification (MAC)
Certificate in Aesthetic Medicine – American Academy of Aesthetic Medicine (AAAM)
Professional Diploma in Dermatology – Royal College Of Physician Of Ireland
LCP Accredited by MOH
Clinical Director of CLÉO CLINIC Kepong

Dr. Sara Thong

Aesthetic Physician

MBBS.(Manipal)
Professional diploma in Aesthetic Medicine – IIWAM
Postgraduate Diploma In Dermatology In Clinical Practice – University Of South Wales, UK
LCP Accredited by MOH
Clinical Director of CLÉO CLINIC Cheras

DISCLAIMER

This article including but not limited to text, graphics, images and other materials is intended for educational purposes only, aiming to encourage a healthy lifestyle. It does not promote the use of anti-obesity medications as a substitute for a balanced diet and regular exercise. Always consult your healthcare provider to ensure the information provided on this page is appropriate for your individual circumstances.